Gender and Race-Based Health Disparities in COVID-19 Outcomes among Hospitalized Patients in the United States: A Retrospective Analysis of a National Sample.
Suman PalKarthik GanguIshan GargHina ShujaAniesh BobbaPrabal ChourasiaRahul ShekharAbu Baker SheikhPublished in: Vaccines (2022)
COVID-19 has brought the disparities in health outcomes for patients to the forefront. Racial and gender identity are associated with prevalent healthcare disparities. In this study, we examine the health disparities in COVID-19 hospitalization outcome from the intersectional lens of racial and gender identity. The Agency for Healthcare Research and Quality (AHRQ) 2020 NIS dataset for hospitalizations from 1 January 2020 to 31 December 2020 was analyzed for primary outcome of in-patient mortality and secondary outcomes of intubation, acute kidney injury (AKI), AKI requiring hemodialysis (HD), cardiac arrest, stroke, and vasopressor use. A multivariate regression model was used to identify associations. A p value of <0.05 was considered significant. Men had higher rates of adverse outcomes. Native American men had the highest risk of in-hospital mortality (aOR 2.0, CI 1.7-2.4) and intubation (aOR 1.8, CI 1.5-2.1), Black men had highest risk of AKI (aOR 2.0, CI 1.9-2.0). Stroke risk was highest in Asian/Pacific Islander women (aOR 1.5, p = 0.001). We note that the intersection of gender and racial identities has a significant impact on outcomes of patients hospitalized for COVID-19 in the United States with Black, Indigenous, and people of color (BIPOC) men have higher risks of adverse outcomes.
Keyphrases
- acute kidney injury
- healthcare
- coronavirus disease
- end stage renal disease
- cardiac arrest
- sars cov
- mental health
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- newly diagnosed
- public health
- prognostic factors
- atrial fibrillation
- cardiac surgery
- middle aged
- african american
- health information
- type diabetes
- human health
- affordable care act
- cardiovascular disease
- case report
- risk assessment
- skeletal muscle
- metabolic syndrome
- subarachnoid hemorrhage